ATE374775T1 - Inhibitoren des hiv-integrase-enzyms - Google Patents

Inhibitoren des hiv-integrase-enzyms

Info

Publication number
ATE374775T1
ATE374775T1 AT05718436T AT05718436T ATE374775T1 AT E374775 T1 ATE374775 T1 AT E374775T1 AT 05718436 T AT05718436 T AT 05718436T AT 05718436 T AT05718436 T AT 05718436T AT E374775 T1 ATE374775 T1 AT E374775T1
Authority
AT
Austria
Prior art keywords
enzyme inhibitors
integrase enzyme
hiv integrase
hiv
inhibitors
Prior art date
Application number
AT05718436T
Other languages
English (en)
Inventor
Klaus Dress
Qiyue Hu
Ted Johnson
Michael Plewe
Steven Tanis
Huichun Zhu
Junhu Zhang
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of ATE374775T1 publication Critical patent/ATE374775T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • AIDS & HIV (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT05718436T 2004-04-26 2005-04-13 Inhibitoren des hiv-integrase-enzyms ATE374775T1 (de)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US56572804P 2004-04-26 2004-04-26
US64331605P 2005-01-11 2005-01-11
US65759405P 2005-02-28 2005-02-28
US66043005P 2005-03-09 2005-03-09

Publications (1)

Publication Number Publication Date
ATE374775T1 true ATE374775T1 (de) 2007-10-15

Family

ID=34964479

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05718436T ATE374775T1 (de) 2004-04-26 2005-04-13 Inhibitoren des hiv-integrase-enzyms

Country Status (10)

Country Link
US (2) US7692014B2 (de)
EP (1) EP1751157B1 (de)
JP (1) JP2007534738A (de)
AT (1) ATE374775T1 (de)
BR (1) BRPI0510306A (de)
CA (1) CA2563761C (de)
DE (1) DE602005002746T2 (de)
ES (1) ES2292123T3 (de)
MX (1) MXPA06012342A (de)
WO (1) WO2005103051A1 (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PA8586801A1 (es) 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
EP1756103A2 (de) 2004-04-26 2007-02-28 Pfizer, Inc. Pyrrolopyridinderivate und deren verwendung als inhibitoren der hiv-integrase
BRPI0510306A (pt) 2004-04-26 2007-09-04 Pfizer inibidores da enzima de hiv integrase,composição farmacêutica contendo os referidos inibidores bem como seu uso
EA200800758A1 (ru) * 2005-10-07 2008-08-29 Пфайзер Продактс Инк. Ингибиторы фермента интегразы вич

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ194747A (en) 1979-08-29 1988-11-29 Schering Ag 9h-pyrido(3,4-b)indol-3-ylcarboxylic acid derivatives
GB8720125D0 (en) 1987-08-26 1987-09-30 Roussel Lab Ltd Chemical compounds
HU212435B (en) * 1990-06-07 1996-06-28 Sandoz Ag Herbicidal compositions containing substituted phthalides and heterocyclic phthalides as active ingredient and process for preparation of their active ingredients.
CA2114728A1 (en) 1991-08-08 1993-02-18 Tetsuro Ikekawa Carcinostatic compound and production thereof
ES2125976T3 (es) * 1992-03-20 1999-03-16 Wellcome Found Otros derivados de indol con accion antiviral.
GB2271566A (en) 1992-10-14 1994-04-20 Merck & Co Inc HIV integrase inhibitors
AU7225494A (en) 1993-07-19 1995-02-20 Zelin Li Qinghaosu derivatives against aids
GB2306476A (en) 1995-10-27 1997-05-07 Merck & Co Inc Hiv integrase inhibitors
US6057297A (en) * 1996-08-06 2000-05-02 Polifarma S.P.A. Inhibitor compounds of zinc-dependent metalloproteinases associated with pathological conditions, and therapeutic use thereof
FR2754262B1 (fr) * 1996-10-08 1998-10-30 Synthelabo Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
EP0949926A4 (de) 1996-10-31 2001-01-17 Merck & Co Inc Benzodiazepin hydrozidderivate als hiv-interase inhibitoren
GB2327674A (en) 1997-07-29 1999-02-03 Merck & Co Inc HIV integrase inhibitors
US6403347B1 (en) * 1998-02-03 2002-06-11 Merck & Co., Inc. HIV integrase inhibitors
AU761020B2 (en) 1998-06-12 2003-05-29 Societe De Conseils De Recherches Et D'applications Scientifiques (S.C.R.A.S.) Beta-carboline compounds
DE60035591D1 (de) * 1999-05-12 2007-08-30 Us Health Thiazepin-hemmer von hiv-1 integrase
US6245806B1 (en) * 1999-08-03 2001-06-12 Merck & Co., Inc. HIV integrase inhibitors
WO2001027309A1 (en) * 1999-10-13 2001-04-19 Merck & Co., Inc. Hiv integrase inhibitors
EP1209158A1 (de) 2000-11-18 2002-05-29 Aventis Pharma Deutschland GmbH Substitutierte beta-Carboline
AU2001266991A1 (en) * 2000-06-16 2002-01-02 Bristol-Myers Squibb Company HIV integrase inhibitors
WO2002002516A2 (en) 2000-06-30 2002-01-10 Thomas Jefferson University Inhibitors of hiv integrase
WO2002070491A1 (fr) 2001-03-01 2002-09-12 Shionogi & Co., Ltd. Derive a noyau heteroaromatique azote presentant une activite d'inhibiteur d'integrase du vih
EP1375486B1 (de) 2001-03-01 2008-10-15 Shionogi & Co., Ltd. Stickstoffhaltige heteroarylverbindungen mit hiv-integrase inhibierender wirkung
JP2003171381A (ja) 2001-09-25 2003-06-20 Takeda Chem Ind Ltd エントリー阻害剤
JP2003119137A (ja) 2001-10-10 2003-04-23 Japan Tobacco Inc Ｈｉｖ阻害剤
DE60216952T2 (de) 2001-10-19 2007-07-05 Transtech Pharma Inc. Beta-carbolin-derivate als ptp-inhibitoren
CA2463975A1 (en) 2001-10-26 2003-05-01 Maria Emilia Di Francesco Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
JP4497347B2 (ja) 2001-12-05 2010-07-07 塩野義製薬株式会社 Ｈｉｖインテグラーゼ阻害活性を有する誘導体
RU2284315C2 (ru) 2001-12-12 2006-09-27 Бристол-Маерс Сквибб Компани Ингибиторы вич-интегразы и содержащие их фармацевтические композиции
CA2472372C (en) 2002-01-17 2010-08-17 Melissa Egbertson Hydroxynaphthyridinone carboxamides useful as hiv integrase inhibitors
CA2478310A1 (en) 2002-03-15 2003-09-25 Merck & Co., Inc. N-(substituted benzyl)-8-hydroxy-1,6-naphthyridine-7-carboxamides useful as hiv integrase inhibitors
WO2003082881A2 (en) * 2002-03-28 2003-10-09 Procyon Biopharma Inc. Pyridoxal-5-phosphate derivatives as hiv integrase inhibitors
EP1499391A2 (de) 2002-04-10 2005-01-26 Merck & Co., Inc. Pharmazeutische zusammensetzungen mit einem hiv-integrase-hemmer und einem nichtionischen tensid
AU2002335027A1 (en) 2002-10-15 2004-05-04 Chiron Corporation Treatment of tnf-alpha-mediated disorders with casein kinase i epsilon inhibitors
PA8586801A1 (es) * 2002-10-31 2005-02-04 Pfizer Inhibidores de hiv-integrasa, composiciones farmaceuticas y metodos para su uso
CA2513141A1 (en) * 2003-01-27 2004-08-12 Pfizer Inc. Hiv-integrase inhibitors, pharmaceutical compositions, and methods for their use
BRPI0510306A (pt) 2004-04-26 2007-09-04 Pfizer inibidores da enzima de hiv integrase,composição farmacêutica contendo os referidos inibidores bem como seu uso
EP1756103A2 (de) * 2004-04-26 2007-02-28 Pfizer, Inc. Pyrrolopyridinderivate und deren verwendung als inhibitoren der hiv-integrase
US20070232644A1 (en) 2004-09-07 2007-10-04 Pfizer Inc. Inhibitors of the Hiv Integrase Enzyme
CA2623534A1 (en) 2005-10-03 2007-04-12 Pfizer Products Inc. Inhibitors of the hiv integrase enzyme
EA200800758A1 (ru) * 2005-10-07 2008-08-29 Пфайзер Продактс Инк. Ингибиторы фермента интегразы вич

Also Published As

Publication number Publication date
MXPA06012342A (es) 2007-01-17
JP2007534738A (ja) 2007-11-29
DE602005002746T2 (de) 2008-02-07
CA2563761C (en) 2009-12-29
US20050277661A1 (en) 2005-12-15
ES2292123T3 (es) 2008-03-01
EP1751157A1 (de) 2007-02-14
DE602005002746D1 (de) 2007-11-15
US7692014B2 (en) 2010-04-06
BRPI0510306A (pt) 2007-09-04
EP1751157B1 (de) 2007-10-03
WO2005103051A1 (en) 2005-11-03
CA2563761A1 (en) 2005-11-03
US20100137283A1 (en) 2010-06-03

Similar Documents

Publication Publication Date Title
WO2005103003A3 (en) Pyrrolopyridine derivatives and their use as hiv-integrase inhibitors
EA200700099A1 (ru) Производные пиридина
MY146669A (en) Pyrazole derivatives for treating hiv
EA200601686A1 (ru) Замещенные производные морфолина и тиоморфолина
MX2010005334A (es) Inhibidores de la replicacion del virus de la inmunodeficiencia humana.
EA200702498A1 (ru) N-(пиридин-2-ил)сульфонамидные производные
DK1585739T3 (da) Substituerede arylcyclopropylacetamider som glucokinaseaktivatorer
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
EA200870193A1 (ru) Цитотоксические агенты, включающие новые производные томаймицина, и их терапевтическое применение
EA200971115A1 (ru) Новые ингибиторы обратной транскриптазы вич
NO20090202L (no) Prolylhydroksylaseinhibitorer
DK1789398T3 (da) 2-amino-quinazolin derivater anvendelige som inhibitorer af B-sekretase (BACE)
IL180495A (en) Benzyl triazolone compounds as non-nucleotide reverse transcriptase inhibitors
EA200801011A1 (ru) Производные пиразина как модуляторы натриевых каналов для лечения боли
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
TW200628153A (en) Novel compounds
ATE374775T1 (de) Inhibitoren des hiv-integrase-enzyms
BR0314860A (pt) Derivados de pirazol
EA200800758A1 (ru) Ингибиторы фермента интегразы вич
NO20051833L (no) 4-(3,5-dicyanofenoksy)pyrazolderivater for anvendelse som transkriptasemodulatorer ved behandling av IA HIV.
BR0314759A (pt) Derivados de pirazol
EA202192111A1 (ru) Новые тритерпеновые производные в качестве ингибиторов вич
TNSN08154A1 (fr) Inhibiteurs de l'enzyme integrase du vih
EA200702590A1 (ru) Ингибиторы растворимой аденилатциклазы

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties